524756 Reaction Screening in an Automated Droplet Screening System for Pharmaceutical Process Development

Michael Wleklinski and Brandon Reizman, Small Molecule Design and Development, Eli Lilly and Company, Indianapolis, IN
See more of this Session: Automation and High-Throughput Technologies for Pharmaceutical Discovery and Development
See more of this Group/Topical: Pharmaceutical Discovery, Development and Manufacturing Forum